XOLREMDI (MAVORIXAFOR) — FDA Approval NDA218709 (X4 PHARMS)
XOLREMDI (MAVORIXAFOR) — FDA Approval NDA218709 (X4 PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: XOLREMDI; Active ingredients: MAVORIXAFOR; Application number: NDA218709.
| Brand name | XOLREMDI |
|---|---|
| Active ingredients | MAVORIXAFOR |
| Application number | NDA218709 |
| Sponsor | X4 PHARMS |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20240426 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →